Lipedema: Pathophysiology, Functional Limitations and Physical Activity Implications – A Narrative Review
DOI:
https://doi.org/10.12775/QS.2026.62.73269Keywords
lipedema, Exercise, Physical Activity, Functional Limitations, Pathophysiology, InflammationAbstract
Lipedema is a chronic adipose tissue disorder characterized by disproportionate accumulation of subcutaneous fat, primarily affecting the lower extremities. The condition occurs almost exclusively in women and is associated with pain, tissue sensitivity, easy bruising, and progressive functional limitations. These symptoms impair mobility and reduce quality of life.
Beyond its characteristic fat distribution, lipedema is increasingly recognized as a complex disorder involving adipose tissue dysfunction, vascular alterations, and impaired physical function. As symptoms progress, many individuals experience reduced physical activity, contributing to further mobility decline.
Exercise is important in conservative management, but evidence remains limited. This narrative review summarizes current knowledge on lipedema pathophysiology, its impact on physical activity, and the role of exercise in disease management.
A literature search was conducted in PubMed, Scopus, and Google Scholar using keywords: "lipedema," "physical activity," "exercise," "inflammation," and "functional limitations." Peer-reviewed studies on pathophysiology, clinical presentation, and exercise-based management were included.
Results: Lipedema involves abnormal fat accumulation, fibrosis, and ECM remodeling, distinguishing it from obesity and driving functional impairment [4,15]. Chronic low-grade inflammation and microvascular dysfunction contribute to pain and reduced mechanical load tolerance [3,4,10]. Pain and discomfort are primary barriers to physical activity, leading to deconditioning [10,24,33]. Low-impact exercise may improve outcomes, but data remain limited [4,10,24]. The literature supports an integrated model where adipose dysfunction, pain, and reduced activity negatively impact functional capacity in lipedema.
References
1 Herbst KL, Kahn LA, Iker E, et al. Standard of care for lipedema in the United States. Phlebology. 2021;36(10):779–796. doi:10.1177/02683555211015887.
2 Kruppa P, Georgiou I, Biermann N, et al. Lipedema—pathogenesis, diagnosis, and treatment options. Dtsch Arztebl Int. 2020;117(22–23):396–403. doi:10.3238/arztebl.2020.0396.
3 Buso G, Depairon M, Tomson D, et al. Lipedema: a call to action! Obesity (Silver Spring). 2019;27(10):1567–1576. doi:10.1002/oby.22597.
4 Poojari A, Dev K, Rabiee A. Lipedema: insights into morphology, pathophysiology, and challenges. Biomedicines. 2022;10(12):3081. doi:10.3390/biomedicines10123081.
5 van der Parra RFD, Deconinck C, Krug B. Diagnostic imaging in lipedema: a systematic review. Obes Rev. 2024;25(1):e13648. doi:10.1111/obr.13648.
6 Reich-Schupke S, Altmeyer P, Stücker M. S1 guidelines: lipedema. J Dtsch Dermatol Ges. 2017;15(7):758–767. doi:10.1111/ddg.13036.
7 Falck F, Rolander B, Nygårdh A, et al. Women with lipedema: health-related quality of life. BMC Womens Health. 2022;22:457. doi:10.1186/s12905-022-02022-3.
8 Romeijn JRM, de Rooij MJM, Janssen L, Martens H. Quality of life in lipedema patients. Dermatol Ther (Heidelb). 2018;8(2):303–311. doi:10.1007/s13555-018-0241-6.
9 Dudek JE, Białaszek W, Gabriel M. Quality of life in Polish women with lipedema. BMC Womens Health. 2021;21:27. doi:10.1186/s12905-021-01174-y.
10 Aitzetmüller-Klietz ML, et al. Pain, physical activity and mental health in lipedema patients. J Clin Med. 2023;12(16):5319. doi:10.3390/jcm12165319.
11 Clarke C, Kirby JN, Smidt T, Best T. Stages of lipedema and health outcomes. Qual Life Res. 2023;32(1):127–137. doi:10.1007/s11136-022-03216-w.
12 Aksoy H, Karadag AS, Wollina U. Lipedema-associated pain mechanisms. Dermatol Ther. 2021;34(1):e14364. doi:10.1111/dth.14364.
13 Katzer KL, Hill JL, McIver KB, Foster MT. Estrogen role in lipedema and adipose tissue accumulation. Int J Mol Sci. 2021;22(21):11720. doi:10.3390/ijms222111720.
14 Paolacci S, et al. Genetics of lipedema: new perspectives on molecular mechanisms. Int J Mol Sci. 2020;21(20):7250. doi:10.3390/ijms21207250.
15 Szél E, Kemény L, Groma G, Szolnoky G. Pathophysiological dilemmas of lipedema. Med Hypotheses. 2014;83(5):599–606. doi:10.1016/j.mehy.2014.08.011.
16 Goss JA, Greene AK. Sensitivity and specificity of the Stemmer sign for lymphedema. Plast Reconstr Surg Glob Open. 2019;7(6):e2295. doi:10.1097/GOX.0000000000002295.
17 Cestari M. 3D ultrasound diagnostics in lipedema. Lymphat Res Biol. 2023;21(5):485–487. doi:10.1089/lrb.2022.0082.
18 Witte T, et al. Water-jet assisted liposuction for lipedema: standardized protocol. J Plast Reconstr Aesthet Surg. 2020;73(9):1637–1644. doi:10.1016/j.bjps.2020.03.002.
19 Kruppa P, et al. Long-term outcomes after liposuction in lipedema patients. Plast Reconstr Surg. 2022;149(3):529e–540e. doi:10.1097/PRS.0000000000008880.
20 Muscogiuri G, et al. VLCKD in obesity management: systematic review. Obes Facts. 2021;14(2):222–245. doi:10.1159/000515381.
21 Cannataro R, et al. Ketogenic diet in lipedema management: follow-up study. Life. 2021;11(12):1402. doi:10.3390/life11121402.
22 Cannataro R, Cione E. Nutraceuticals in lipedema: scientific use. Nutraceuticals. 2022;2(4):20. doi:10.3390/nutraceuticals2040020.
23 Keith L, et al. Ketogenic diet as potential intervention for lipedema. Med Hypotheses. 2021;146:110435. doi:10.1016/j.mehy.2020.110435.
24 Malm IA, Nilsson PV, Hurtig-Wennlöf A. Objective physical activity in lipedema. BMC Womens Health. 2026;26:50. doi:10.1186/s12905-026-04271-y.
25 Forner-Cordero I, et al. Management of lipedema: multidisciplinary approach. Int Angiol. 2021;40(4):345–357. doi:10.23736/S0392-9590.21.04752-2.
26 Szolnoky G, et al. Capillary fragility in lipedema. Lymphology. 2017;50(4):210–216.
27 Czerwińska M, et al. Compression therapy in lipedema patients. Int J Environ Res Public Health. 2023;20(2):914. doi:10.3390/ijerph20020914.
28 Warren Peled WP, Kappos EA. Diagnostic challenges in lipedema. Int J Womens Health. 2016;8:389–395. doi:10.2147/IJWH.S106227.
29 Okhovat JP, Alavi A. Lipedema review of literature. Int J Low Extrem Wounds. 2015;14(3):262–267. doi:10.1177/1534734614554284.
30 Reich-Schupke S, et al. Differential diagnosis lipedema vs obesity. J Dtsch Dermatol Ges. 2013;11(3):225–233. doi:10.1111/ddg.12024.
31 Amato ACM, Saucedo DZ, Santos KDS, Benitti DA. Ultrasound criteria for lipedema diagnosis. Phlebology. 2021;36(8):651–658. doi:10.1177/02683555211002340.
32 von Atzigen J, Burger A, Grünherz L, et al. A comparative analysis to dissect the histological and molecular differences among lipedema, lipohypertrophy and secondary lymphedema. Int J Mol Sci. 2023;24(8):7591. doi:10.3390/ijms24087591.
33 Pervane S, Uzun Ö. Neuropathic pain features in lipedema compared to lymphedema: an exploratory cross-sectional study. Lymphat Res Biol. 2026. doi:10.1177/15578585261454778. Epub ahead of print.
34 Bettariga F, Fumagalli L, Aloisi D, Maestroni L, Mantovani S. Characterization of pain in lipedema: reliability and validity of pain pressure thresholds and hand-held sphygmomanometer assessments in people with lipedema. Lymphat Res Biol. 2025;23(2):95-100. doi:10.1089/lrb.2024.0012.
35 Al-Ghadban S, Evancio JV, Alfiscar PEF, Herbst KL. New characterization of lipedema stages: focus on pain, water, fat and skeletal muscle. Life (Basel). 2025;15(9):1397. doi:10.3390/life15091397.
36 Chachaj A, Fleszar M, Lewandowski Ł, et al. Changes in vascular, lymphatic, inflammatory, and lipid mediators during a 7-month calorie-restricted low-carbohydrate, high-fat dietary intervention in women with lipedema: a preliminary prospective study. Nutrients. 2026;18(9):1381. doi:10.3390/nu18091381.
37 Stellmaker R, Thompson B, Mackie H, et al. A retrospective cross-sectional study comparing health-related quality-of-life in females with lipoedema and bilateral leg lymphoedema. J Psychosom Res. 2026;203:112562. doi:10.1016/j.jpsychores.2026.112562.
38 Głowacka J, et al. Lipedema: diagnosis, treatment and vicious cycle. Qual Sport. 2025;38:57746. doi:10.12775/QS.2025.38.57746.
39 de Oliveira J, de Paula ACP, Guimarães VHD. Clinical or cultural? Dietary interventions for lipedema: a systematic review. Maturitas. 2025;202:108716. doi:10.1016/j.maturitas.2025.108716.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Karolina Karwat, Stanisław Gut, Jakub Miarczyński, Nikola Wiercińska, Juliusz Widelski, Szymon Woźniak

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 173
Number of citations: 0